Imported severe Plasmodium falciparum infection in the first trimester of pregnancy complicated by post-artemisinin delayed hemolysis and intrauterine fetal death, a case report

Tropical Medicine and Health
Kohei Kamegai1, Kayoko Hayakawa1, Kei Yamamoto1, Hidetoshi Nomoto1, Kanako Komaki-Yasuda2, Shigeyuki Kano2, Norio Ohmagari1
1Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
2Department of Tropical Medicine and Malaria, National Center for Global Health and Medicine, Tokyo, Japan

Tóm tắt

Abstract Background Post-artemisinin delayed hemolysis (PADH) is a serious complication in patients who recover from severe malaria after receiving artemisinin-based combined therapy (ACT), including artemether-lumefantrine. In Japan, among the antimalarial drugs recommended by the World Health Organization (WHO) guideline for severe malaria, intravenous quinine gluconate is available only in 29 designated hospitals, and intravenous artesunate is unavailable. Therefore, oral artemether-lumefantrine is occasionally administered as an alternative, even though it may be a suboptimal treatment. In non-endemic settings like Japan, a lack of knowledge of malaria and the side effects, such as post-artemisinin delayed hemolysis caused by the ACT, can have critical consequences. Like our patient, being a primigravida in the early stages of pregnancy is a serious risk factor for severe malaria and must be carefully monitored. Case presentation This report describes a severe case of imported Plasmodium falciparum malaria complicated by fetal loss and prolonged anemia, requiring frequent blood transfusions. The patient was a previously healthy pregnant Japanese female in her 30 s. She developed a high fever 2 days after returning from Nigeria. The patient fulfilled the severe malaria criteria by WHO. On arrival, an abdominal ultrasound incidentally revealed a fetus of 5 week gestational age with a heartbeat in the uterus. Given her pregnancy and the severity of the disease, she was administered intravenous quinine 16 mg/kg as a loading dose. However, the second dose of quinine was not administered due to frequent vomiting and QTc prolongation. We initiated treatment with oral artemether-lumefantrine, and clearance of parasitemia was confirmed by microscopic observation on day 4. Miscarriage was noted on day 6 after admission. Moreover, the patient became feverish again up to 39 °C, and from days 14 to 22, the patient required multiple blood transfusions due to PADH. On day 40, follow-up was discontinued as the hemoglobin level exceeded 10 g/dL. Conclusions In patients who recover from severe malaria after ACT treatment, monitoring the hemoglobin level for at least a month is strongly recommended for prompt identification of PADH. Travelers to malaria-endemic countries, especially primigravida women, should be provided with adequate information on the risk and prevention of infection.

Từ khóa


Tài liệu tham khảo

Kanayama A, et al. Epidemiology of imported malaria cases in Japan, 2006–2014: a sentinel traveler surveillance approach. Am J Trop Med Hyg. 2017;97(5):1532–9.

WHO Guidelines for malaria. https://www.who.int/publications/i/item/guidelines-for-malaria updated on 25 November 2022. Accessed 9 Dec 2022.

CDC guideline for malaria. https://www.cdc.gov/malaria/resources/pdf/Malaria_Trx_Guide_for_US_Clinicians_202208.pdf updated in August 2022. Accessed 9 Dec 2022.

Guideline for drug treatment of parasitosis https://www.nettai.org/. Accessed 30 Oct 2022. (Japanese)

Arguin PM, et al. Case definition: postartemisinin delayed hemolysis. Blood. 2014;124(2):157–8.

Kurth F, et al. Hemolysis after oral artemisinin combination therapy for uncomplicated Plasmodium falciparum malaria. Emerg Infect Dis. 2016;22(8):1381–6. https://doi.org/10.3201/eid2208.151905.

Rolling T, et al. Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focusing on delayed haemolysis. Malar J. 2013;12:241. https://doi.org/10.1186/1475-2875-12-241.

Chotivanich K, et al. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis. 2000;182(2):629–33. https://doi.org/10.1086/315718.

Bartoli TA, et al. Systematic analysis of direct anti-globulin test results in post-artesunate delayed haemolysis. Malar J. 2021;20(1):206. https://doi.org/10.1186/s12936-021-03735-w.

Ndour PA, et al. Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis. Sci Transl Med. 2017;9(397):eaaf9377. https://doi.org/10.1126/scitranslmed.aaf9377.

Corpolongo A, et al. Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine. Malar J. 2012;27(11):91. https://doi.org/10.1186/1475-2875-11-91.

De Nardo P, et al. Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria. Infection. 2013;41(4):863–5. https://doi.org/10.1007/s15010-013-0451-x.

Raffray L, et al. Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report. Malar J. 2014;13:398. https://doi.org/10.1186/1475-2875-13-398.

Tsuchido Y, et al. Development of delayed hemolytic anemia after treatment with oral artemether-lumefantrine in two patients with severe falciparum malaria. Am J Trop Med Hyg. 2017;96(5):1185–9. https://doi.org/10.4269/ajtmh.16-0460.

Lebrun D, et al. Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report. J Travel Med. 2018. https://doi.org/10.1093/jtm/tax091.

Hasegawa C, et al. Severe delayed haemolytic anaemia associated with artemether-lumefantrine treatment of malaria in a Japanese traveller. J Infect Chemother. 2018;24(3):216–9. https://doi.org/10.1016/j.jiac.2017.10.008.

Nakamura-Uchiyama F, et al. Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan. Travel Med Infect Dis. 2018;22:40–5. https://doi.org/10.1016/j.tmaid.2018.02.003.

Conlon CC, et al. Post-artemisinin delayed hemolysis after oral therapy for P. falciparum infection. ID Cases. 2020;20: e00741. https://doi.org/10.1016/j.idcr.2020.e00741.

Gustafsson L, et al. Fatal case of delayed-onset haemolytic anaemia after oral artemether-lumefantrine. BMJ Case Rep. 2021;14(11): e245718. https://doi.org/10.1136/bcr-2021-245718.

Clinton KP, Thévenon AD, Zhou JA, Taylor DW. Influence of human chorionic gonadotropin (hCG) on in vitro growth of Plasmodium falciparum. Malar J. 2009;14(8):101. https://doi.org/10.1186/1475-2875-8-101.

Pandya Y, Penha-Gonçalves C. Maternal-fetal conflict during infection: lessons from a mouse model of placental malaria. Front Microbiol. 2019;24(10):1126. https://doi.org/10.3389/fmicb.2019.01126.

World Health Organization. Guideline for malaria. Updated on 3 June 2022. https://apps.who.int/iris/bitstream/handle/10665/354781/WHO-UCN-GMP-2022.01-Rev.2-eng.pdf?sequence=1&isAllowed=y. Accessed 15th Jan 2023.

Dellicour S, et al. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLoS Med. 2017;14(5): e1002290. https://doi.org/10.1371/journal.pmed.1002290.

Thông tin
Thông tin xuất bản

Tropical Medicine and Health

Thông tin tác giả